The first half of 2025 has introduced new challenges and uncertainty within the health care ecosystem. Between the tariffs, restructuring of HHS, deregulation, Executive Orders, the "One Big Beautiful Bill Act," and proposed 2026 President's budget, health care providers, payors, manufacturers, and vendors operating in the industry are facing new challenges. Similarly, this uncertainty raises a number of issues and considerations with respect to potential transactions in this space.
As companies, private equity firms, and other investors think about deals, they need to be able to identify, assess, and potentially mitigate and protect themselves from some of these risks.
During this discussion, panelists from Mintz and Marsh will walk through some of the risks and discuss available tools and best practices to address them.
Agenda:
- Risks and Uncertainty Impacting Health Care Companies and Stakeholders
- Addressing the Risks Through Diligence
- Drafting and Addressing Risks through Deal Documents
- RWI Coverage Considerations and Market Update
- Addressing D&O risk through the transaction process
- Impact of Tariffs and tax dynamics on the transaction environment
- IPO insurance solutions
Mintz is an accredited CLE provider in California and New York. This program is approved for 1.0 hour of General credit in California and 1.0 hour of Professional Practice credit in New York. Participants will also receive a uniform certificate of attendance, which may be used to self-apply for CLE credit in other jurisdictions.
When
Thursday, September 18, 2025
12:00 PM - 1:00 PM EST
Where
This is a virtual event. The zoom link will be provided after registration.
Moderator
Katya Daniel, Member, Mintz
Speakers
Elizabeth Cunnane, Managing Director – Transactional Risk, Marsh
Ruth Kochenderfer, Managing Director – National D&O Leader, Marsh
Lauren Moldawer, Member, Mintz